Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

322 Views

Favorite
Facebook
Tweet
Print

Session: Why Do We Do This? Exploring the Data Behind Long-Established Practices in ID 

698 - IV or Not IV? That Is the Duration. An update on routes and durations of therapy for bactermia.

Wednesday, October 22, 2025

4:05 PM - 4:30 PM US ET

Location: B308-B309

Speaker(s)

JG

Jason Gallagher, PharmD

Clinical Professor
Temple University
Philadelphia, PA, United States

Slides

Disclosure(s):

Jason Gallagher, PharmD: AbbVie Inc: Advisor/Consultant, Honoraria; GSK/ViiV Healthcare: Advisor/Consultant, Honoraria; Invivyd: Advisor/Consultant, Honoraria; Meitheal pharmaceuticals: Advisor/Consultant, Honoraria; Merck and Company, Inc.: Advisor/Consultant, Grant/Research Support, Honoraria; Novavax, Inc.: Advisor/Consultant, Honoraria; SHIONOGI and CO., LTD.: Advisor/Consultant, Honoraria